未登录.png)
分享.png)
收藏Investigation of clinical and genetic characteristics of Alport syndrome using a national registry in Japan (JP-ALPS)使用日本国家登记系统(JP-ALPS)调查Alport综合征的临床和遗传特征
Okuda, Yusuke; Mikami, Naoaki; Hamada, Riku; Hataya, Hiroshi; Tanaka, Kazuki; Terano, Chikako; Fujita, Naoya; Miura, Kenichiro; Ishizuka, Kiyonobu; Shirai, Yoko; Kamei, Koichi; Ogura, Masao; Okamoto, Takayuki; Suzuki, Ryota; Shinozuka, Shunsuke; Shima, Yuko; Oka, Masafumi; Shimabukuro, Wataru; Tsukaguchi, Hiroyasu; Inagaki, Tetsuji; Nishiyama, Kei; Hashimoto, Taeko; Ito, Naoko; Yamamura, Tomohiko; Horinouchi, Tomoko; Ishikura, Kenji; Nakanishi, Koichi; Nozu, Kandai 分享 收藏 分享 收藏 Frequent copy number gain of MCL1 is a therapeutic target for osteosarcomaTakagi, Satoshi; Nakajima, Mikako; Koike, Sumie; Takami, Miho; Sugiura, Yoshiya; Sakata, Seiji; Baba, Satoko; Takemoto, Ai; Huang, Tianyi; Seto, Yosuke; Saito, Masanori; Funauchi, Yuki; Ae, Keisuke; Takeuchi, Kengo; Fujita, Naoya; Katayama, Ryohei 分享 收藏 In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues使用在血管化三维基质组织上培养的患者来源的细胞系体外通量筛选抗癌药物Takahashi, Yuki; Morimura, Rii; Tsukamoto, Kei; Gomi, Sayaka; Yamada, Asuka; Mizukami, Miki; Naito, Yasuyuki; Irie, Shinji; Nagayama, Satoshi; Shinozaki, Eiji; Yamaguchi, Kensei; Fujita, Naoya; Kitano, Shiro; Katayama, Ryohei; Matsusaki, Michiya 分享 收藏 分享 收藏 A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancerSuzuki, Mai; Uchibori, Ken; Oh-hara, Tomoko; Nomura, Yumi; Suzuki, Ryusei; Takemoto, Ai; Araki, Mitsugu; Matsumoto, Shigeyuki; Sagae, Yukari; Kukimoto-Niino, Mutsuko; Kawase, Yusuke; Shirouzu, Mikako; Okuno, Yasushi; Nishio, Makoto; Fujita, Naoya; Katayama, Ryohei 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinomaBRAF V600E突变阳性结直肠神经内分泌癌中BRAF剪接变异体介导的获得性耐药Shimizu, Yuki; Maruyama, Kohei; Suzuki, Mai; Kawachi, Hiroshi; Low, Siew-Kee; Oh-hara, Tomoko; Takeuchi, Kengo; Fujita, Naoya; Nagayama, Satoshi; Katayama, Ryohei 分享 收藏 Targeting Podoplanin for the Treatment of OsteosarcomaTakemoto, Ai; Takagi, Satoshi; Ukaji, Takao; Gyobu, Nobuhiko; Kakino, Mamoru; Takami, Miho; Kobayashi, Asami; Lebel, Marie; Kawaguchi, Tokuichi; Sugawara, Minoru; Tsuji-Takayama, Kazue; Ichihara, Kenji; Funauchi, Yuki; Ae, Keisuke; Matsumoto, Seiichi; Sugiura, Yoshiya; Takeuchi, Kengo; Noda, Tetsuo; Katayama, Ryohei; Fujita, Naoya 分享 收藏 GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancerShimizu, Yuki; Okada, Koutaroh; Adachi, Jun; Abe, Yuichi; Narumi, Ryohei; Uchibori, Ken; Yanagitani, Noriko; Koike, Sumie; Takagi, Satoshi; Nishio, Makoto; Fujita, Naoya; Katayama, Ryohei 分享 收藏 Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylationSagawa, Ray; Sakata, Seiji; Gong, Bo; Seto, Yosuke; Takemoto, Ai; Takagi, Satoshi; Ninomiya, Hironori; Yanagitani, Noriko; Nakao, Masayuki; Mun, Mingyon; Uchibori, Ken; Nishio, Makoto; Miyazaki, Yasunari; Shiraishi, Yuichi; Ogawa, Seishi; Kataoka, Keisuke; Fujita, Naoya; Takeuchi, Kengo; Katayama, Ryohei 分享 收藏 Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis血小板衍生的溶血磷脂酸介导的LPAR1活化作为骨肉瘤转移的治疗靶点Takagi, Satoshi; Sasaki, Yuki; Koike, Sumie; Takemoto, Ai; Seto, Yosuke; Haraguchi, Mizuki; Ukaji, Takao; Kawaguchi, Tokuichi; Sugawara, Minoru; Saito, Masanori; Funauchi, Yuki; Ae, Keisuke; Matsumoto, Seiichi; Fujita, Naoya; Katayama, Ryohei 分享 收藏 Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivityYoshizawa, Takahiro; Uchibori, Ken; Araki, Mitsugu; Matsumoto, Shigeyuki; Ma, Biao; Kanada, Ryo; Seto, Yosuke; Oh-hara, Tomoko; Koike, Sumie; Ariyasu, Ryo; Kitazono, Satoru; Ninomiya, Hironori; Takeuchi, Kengo; Yanagitani, Noriko; Takagi, Satoshi; Kishi, Kazuma; Fujita, Naoya; Okuno, Yasushi; Nishio, Makoto; Katayama, Ryohei 分享 收藏 Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancerGilteritinib克服了ALK重排癌症的lorlatinib耐药性Mizuta, Hayato; Okada, Koutaroh; Araki, Mitsugu; Adachi, Jun; Takemoto, Ai; Kutkowska, Justyna; Maruyama, Kohei; Yanagitani, Noriko; Oh-hara, Tomoko; Watanabe, Kana; Tamai, Keiichi; Friboulet, Luc; Katayama, Kazuhiro; Ma, Biao; Sasakura, Yoko; Sagae, Yukari; Kukimoto-Niino, Mutsuko; Shirouzu, Mikako; Takagi, Satoshi; Simizu, Siro; Nishio, Makoto; Okuno, Yasushi; Fujita, Naoya; Katayama, Ryohei 分享 收藏 TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathwaysMiura, Akihiro; Sootome, Hiroshi; Fujita, Naoya; Suzuki, Takamasa; Fukushima, Hiroto; Mizuarai, Shinji; Masuko, Norio; Ito, Kimihiro; Hashimoto, Akihiro; Uto, Yoshihiro; Sugimoto, Tetsuya; Takahashi, Hidekazu; Mitsuya, Morihiro; Hirai, Hiroshi 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
